...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>European addiction research >Is Medicine Use for Nervousness Associated with Adolescent At-Risk or Problem Gambling?
【24h】

Is Medicine Use for Nervousness Associated with Adolescent At-Risk or Problem Gambling?

机译：是药物用于与青少年风险或赌博有关的紧张性吗？

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: To examine the association between adolescent at-risk or problem gambling (ARPG) and medicine used to treat nervousness in a large-scale nationally representative sample of Italian adolescents. Study design: Data from the 2013/2014 Health Behaviour in School-aged Children Survey was used for cross-sectional analyses (a sample of 20,791 15-year-old students). Self-administered questionnaires were completed by a representative sample of high-school students. Respondents' ARPG, use of medicine for nervousness and potential confounding factors were assessed. Multilevel logistic regression analyses were used to test the association between medicine use to treat nervousness and ARPG. Results: The overall prevalence of adolescents reporting medicine use for nervousness in the last month was 6.3%. The odds of ARPG were 3 times higher among adolescents who used medicine for nervousness compared to that among adolescents who did not take such medicine (OR 2.96, 95% CI 2.07-4.25). Importantly, the association between medicine used to treat nervousness and ARPG did not vary significantly when viewed in light of psychological symptoms. Conclusions: Medicine use to treat nervousness is associated with increased risk of gambling-related harm. (C) 2017 S. Karger AG, Basel
机译：目的：审查青少年风险或问题赌博（ARPG）和用于治疗意大利青少年的大规模国家代表性样本的神经的关联。研究设计：2013/2014学校儿童卫生行为的数据用于横断面分析（20,791名15岁学生的样本）。自我管理的调查问卷由高中生代表性的样本完成。受访者的ARPG，评估使用药物和潜在的混杂因子。使用多级逻辑回归分析来测试药物用于治疗神经性和ARPG之间的关联。结果：上个月在上个月内报告医学用药的总体普遍性为6.3％。与未采用此类药物（或2.96,95％CI 2.07-4.25）的青少年相比，ARPG的arpg的几率在使用医学的青少年中占用的青少年的3倍。重要的是，在心理症状观察时，用于治疗紧张性和ARPG的药物之间的关联并没有显着变化。结论：药物用于治疗紧张性与赌博相关伤害的风险增加有关。 （c）2017年S. Karger AG，巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号